Bio-Rad Laboratories, Inc. Class A Common Stock vs Manulife Financial Corporation — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Manulife Financial Corporation trades at $41.3 (market cap $68.47B). The key difference: Manulife Financial Corporation is far larger — about 8.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Manulife Financial Corporation pays a 3.23% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | MFC | |
|---|---|---|
Market Cap | $8.02B | $68.47B |
Sector | Health | Financials |
52-Week High | $339.75 | $41.69 |
52-Week Low | $241.71 | $29.90 |
Enterprise Value | $7.84B | $65.03B |
Dividend Yield | — | 3.23% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →